Evidence map›Paper›PMID 37275886›Full record

ArticleFrontiers in immunology2023

Impact of peptide:HLA complex stability for the identification of SARS-CoV-2-specific CD8

Olivia Lie-Andersen, Mie Linder Hübbe, Krishanthi Subramaniam, Daniel Steen-Jensen, Ann Christina Bergmann, Daniel Justesen, Morten Orebo Holmström, Lance Turtle, Sune Justesen, Telma Lança and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Instability of the HLA-E peptidome of HIV presents a major barrier to therapeutic targeting.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Olivia Lie-AndersenImmunitrack ApS, Copenhagen, Denmark.
Mie Linder HübbeImmunitrack ApS, Copenhagen, Denmark.
Krishanthi SubramaniamInstitute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.
Daniel Steen-JensenImmunitrack ApS, Copenhagen, Denmark.
Ann Christina BergmannImmunitrack ApS, Copenhagen, Denmark.
Daniel JustesenImmunitrack ApS, Copenhagen, Denmark.
Morten Orebo HolmströmNational Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
Lance TurtleInstitute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.
Sune JustesenImmunitrack ApS, Copenhagen, Denmark.
Telma LançaImmunitrack ApS, Copenhagen, Denmark.
Morten HansenNational Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
Copenhagen University Hospital · DKUniversity of Liverpool · GBTechnical University of Denmark · DK

Funding

Department of Health NIHR200907Wellcome Trust 205228/Z/16/Z
6 · The paper itself

Abstract

Induction of a lasting protective immune response is dependent on presentation of epitopes to patrolling T cells through the HLA complex. While peptide:HLA (pHLA) complex affinity alone is widely exploited for epitope selection, we demonstrate that including the pHLA complex stability as a selection parameter can significantly reduce the high false discovery rate observed with predicted affinity. In this study, pHLA complex stability was measured on three common class I alleles and 1286 overlapping 9-mer peptides derived from the SARS-CoV-2 Spike protein. Peptides were pooled based on measured stability and predicted affinity. Strikingly, stability of the pHLA complex was shown to strongly select for immunogenic epitopes able to activate functional CD8

Indexed as

COVID-19SARS-CoV-2CD8-Positive T-LymphocytesEpitopes, T-LymphocyteHistocompatibility AntigensHumansPeptidesSpike Glycoprotein, CoronavirusEpitopes, T-LymphocyteHistocompatibility AntigensPeptidesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2affinityCOVID-19epitopeflow cytometryNeoScreen stability assayPBMCpHLAtetramer

Identifiers

PMID37275886
PMCPMC10232890
OpenAlexW4379508040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.